Gradual dosing of Lilly drug for Alzheimer’s disease reduces risk of brain swelling 

Starting a more gradual dosing schedule for Eli Lilly's Alzheimer's disease drug Kisunla reduces the percentage of patients suffering from potentially serious brain swelling, according to interim results from a…

Continue ReadingGradual dosing of Lilly drug for Alzheimer’s disease reduces risk of brain swelling